Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
Alexandre R. Zlotta, Leslie Ballas, Andrzej Niemierko, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 6, pp. 669-681
Closed Access | Times Cited: 118

Showing 26-50 of 118 citing articles:

Understanding patient perspectives in the management of their muscle‐invasive bladder cancer
Deepro Chowdhury, Andrea B. Apolo, Di Jiang, et al.
BJU International (2025)
Closed Access
Aplicaciones clínicas de la resonancia magnética de vejiga: más allá de la clasificación VIRADS®
J. Etxano, A. López-Maseda
Radiología (2025)
Closed Access
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
Antoine G. van der Heijden, Harman Max Bruins, Albert Carrión, et al.
European Urology (2025)
Closed Access
Online Adaptive Radiotherapy for Bladder Preservation: Transitioning to Hypofractionation
Anuradha Krishnan, Priyamvada Maitre, Sheetal Kashid, et al.
International Journal of Radiation Oncology*Biology*Physics (2025)
Closed Access
Online adaptive radiotherapy for bladder cancer using a simultaneous integrated boost and fiducial markers
Sana Azzarouali, Karin Goudschaal, J. Visser, et al.
Radiation Oncology (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 11
The effect of race/ethnicity on cancer-specific mortality after trimodal therapy
Mario de Angelis, Andrea Baudo, Carolin Siech, et al.
Journal of Racial and Ethnic Health Disparities (2024)
Closed Access | Times Cited: 3
Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled Trial
Robert Huddart, S. Hafeez, Clare Griffin, et al.
European Urology (2024)
Open Access | Times Cited: 3
Trimodality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Matched Cohort Studies
Akihiro Matsukawa, Takafumi Yanagisawa, Marcin Miszczyk, et al.
European Urology Focus (2024)
Closed Access | Times Cited: 3
A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial
Timothy Smith, Catharine West, Nuradh Joseph, et al.
EBioMedicine (2024) Vol. 101, pp. 105032-105032
Open Access | Times Cited: 3
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)
Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, et al.
European Urology Oncology (2023) Vol. 7, Iss. 3, pp. 469-477
Closed Access | Times Cited: 8
Cutaneous Ureterostomy Following Radical Cystectomy for Bladder Cancer: A Contemporary Series
Reza Nabavizadeh, Rodrigo Rodrigues Pessoa, Mihai Dumbravă, et al.
Urology (2023) Vol. 181, pp. 162-166
Closed Access | Times Cited: 7
Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer
Sophia C. Kamran, Yuzhen Zhou, Keisuke Otani, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 24, pp. 5116-5127
Open Access | Times Cited: 7
Controversy Surrounding Bladder-Sparing Radical Dose Radiotherapy as an Alternative to Radical Cystectomy for Clinically Node-Positive Nonmetastatic Bladder Cancer
Wei He, Shuxiong Zeng, Chuanliang Xu
Journal of Clinical Oncology (2023) Vol. 42, Iss. 5, pp. 614-615
Closed Access | Times Cited: 7
Comparative survival analysis of bladder preservation therapy versus radical cystectomy in muscle‐invasive bladder cancer
Nai‐Wen Kang, Yin‐Hsun Feng, Kuei‐Li Lin, et al.
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 2
Temporal trends and cancer-specific mortality in non-metastatic muscle-invasive urothelial carcinoma of the urinary bladder treated with trimodal therapy
Mario de Angelis, Lukas Scheipner, Carolin Siech, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 4, pp. 102119-102119
Closed Access | Times Cited: 2
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels
Laura S. Mertens, H.M. Bruins, Roberto Contieri, et al.
European Urology Oncology (2024)
Closed Access | Times Cited: 2
Three-Dimensional Printing Creates New Trends of the Technological Revolution in Urologic Surgery
Ruicheng Wu, Jie Wang, Dengxiong Li, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 8, pp. 3414-3435
Open Access | Times Cited: 2
Long-Term Results of Bladder Preservation with Twice-Daily Radiation plus 5-Flourouracil/Cisplatin or Daily Radiation plus Gemcitabine for MIBC – Updated Report of NRG/RTOG 0712: A Randomized Phase 2 Trial
John J. Coen, Joseph P. Rodgers, Philip J. Saylor, et al.
International Journal of Radiation Oncology*Biology*Physics (2024)
Closed Access | Times Cited: 2
Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
Yongsoo Jo, Hyeong Dong Yuk
Journal of Urologic Oncology (2024) Vol. 22, Iss. 3, pp. 256-267
Closed Access | Times Cited: 2
The association between frailty, hypogonadism, and postoperative outcomes among men undergoing radical cystectomy
Daniel R. Greenberg, Stephen Rhodes, Hriday P. Bhambhvani, et al.
Urologic Oncology Seminars and Original Investigations (2024) Vol. 42, Iss. 5, pp. 161.e9-161.e16
Closed Access | Times Cited: 1
Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a qualitative study exploring patient priorities and counselling needs when making a treatment choice
Flor Verghote, Charles Van Praet, Camille Berquin, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database
Annamaria Porreca, Marta Di Nicola, Giuseppe Lucarelli, et al.
Urologic Oncology Seminars and Original Investigations (2024) Vol. 42, Iss. 3, pp. 69.e17-69.e25
Open Access | Times Cited: 1
Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancer
Martin Swinton, Aarani Devi, Yee Pei Song, et al.
World Journal of Urology (2024) Vol. 42, Iss. 1
Open Access | Times Cited: 1
Bladder tumour focused adaptive radiotherapy: Clinical outcomes of a phase I dose escalation study
S. Hafeez, K. Warren-Oseni, Kelly Jones, et al.
International Journal of Radiation Oncology*Biology*Physics (2024)
Open Access | Times Cited: 1
CT-Guided Online Adaptive Hypofractionated Radiotherapy for Primary Bladder Cancer: A Report of Two Cases
Ryan M. Davis, Colton Ladbury, Kevin Tsai, et al.
Cureus (2024)
Open Access | Times Cited: 1

Scroll to top